Rabeprazole contains the active component Rabeprazole. This medication belongs to a class of drugs known as proton pump inhibitors (PPIs). It is commonly prescribed to treat excess stomach acid production conditions, such as gastroesophageal reflux disease (GERD), gastric ulcers, and Zollinger-Ellison syndrome. Zollinger-Ellison syndrome is a rare condition characterized by the overproduction of stomach acid. Rabeprazole helps relieve excess stomach acid production symptoms, such as heartburn, regurgitation, chest pain, and acid indigestion. Reducing the amount of acid in the stomach can alleviate discomfort and improve quality of life. Rabeprazole received initial FDA approval on February 19, 1999.

Rabeprazole treats various conditions related to excessive stomach acid production, including gastroesophageal reflux disease (GERD), duodenal ulcers, gastric ulcers, and Zollinger-Ellison syndrome.

Rabeprazole is taken orally, once daily, with or without food. The dosage and duration of treatment depend on the specific condition being treated. It is important to follow the instructions provided by your healthcare provider or the medication label. Swallow the tablet whole with water and do not crush, chew, or split it.

Rabeprazole can potentially cause common side effects such as headache, diarrhea, abdominal pain, nausea, and flatulence. Less frequently, it may lead to serious side effects, including severe allergic reactions, stomach pain, persistent diarrhea, muscle weakness, changes in heartbeat, and signs of liver problems.

Rabeprazole carries several important warnings. Prolonged use may increase the risk of gastrointestinal infections, including Clostridium difficile-associated diarrhea, and may slightly elevate the risk of bone fractures in older adults. It can also lead to low magnesium levels and vitamin B12 deficiency. This medication may interact with certain medications and interfere with diagnostic tests. Rare hypersensitivity reactions have been reported.

When using rabeprazole, precautions include regularly monitoring magnesium and vitamin B12 levels, caution in individuals with liver disease, awareness of potential medication interactions, and consulting with healthcare providers during pregnancy, breastfeeding, or with pediatric patients. Close monitoring is advised for elderly individuals.

Regarding your health and medication usage, it is important to prioritize open communication with your healthcare provider. Make sure to provide them with a comprehensive overview of your medical history, including any existing conditions, medications you are currently taking, or any allergies you may have. Regular monitoring of magnesium levels and consideration of magnesium supplementation may be necessary, particularly with long-term use. Vitamin B12 levels should also be monitored, and supplementation may be required. Also, pregnant or breastfeeding individuals should consult their healthcare provider before using. Pediatric patients should use it cautiously; the medication is generally not recommended for children under 12. Elderly individuals may be at an increased risk of certain side effects, so close monitoring is necessary.

1. I.D. Penman, C.W. Lees, Alimentary tract and pancreatic disease, Davidson’s Principles & Practice of Medicine, 22nd Edition, 2014, 837-920
2. FSC Laboratories, Inc. U.S Food and Drug Safety administration [Revised on December 2014], [Accessed on 8th June 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020973s035204736s005lbl.pdf

The drug information on this page is different from medical advice. It is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you can receive this treatment.